Press releases

These press releases are intended for business journalists and analysts/investors

GSK’s malaria candidate vaccine, MosquirixTM (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa

WHO will now assess how the world’s first malaria candidate vaccine might be used alongside other tools to prevent malaria

Read more - GSK’s malaria candidate vaccine, MosquirixTM (RTS,S), receives positive opinion from European regulators for the prevention of malaria in young children in sub-Saharan Africa Read more